Projects

Ing. Štefan Zorad, CSc.

National

Current
  • Verification of positive effect of fructose - methyl cellulose treatment on rat metabolism.
    Program: VEGA
    Duration: 1. 1. 2024 – 31. 12. 2026
Finished
  • Cardiometabolic effects of Mas receptor stimulation by modulation of the renin-angiotensin system - the key role of angiotensin-converting enzyme 2.
    Program: SRDA
    Duration: 1. 7. 2021 – 30. 6. 2025
  • Regulation of preadipocyte differentiation and adipocyte metabolism by oxidative stress in rat and human tissue culture.
    Program: VEGA
    Duration: 1. 1. 2020 – 31. 12. 2022
  • New perspectives in the treatment of cardiovascular complications associated with COVID-19
    Program: SRDA
    Duration: 16. 9. 2020 – 31. 12. 2021
  • Experimental approaches in vitro and in vivo to inovative therapy of rheumatoid arthritis based on molecular-pharmacological principles
    Program: SRDA
    Duration: 1. 7. 2016 – 31. 12. 2020
  • Effect of flavonoids and mycotoxins on adipose tissue. The influence of metabolic status, inflammation and oxidative stress
    Program: SRDA
    Duration: 1. 7. 2016 – 31. 12. 2020
  • New regulatory effects of nitric oxide and their role in the development of essential hypertension
    Program: SRDA
    Duration: 1. 7. 2016 – 31. 8. 2020
  • The effect of IRAP (insulin-regulated aminopeptidase) aminopeptidase activity inhibition on metabolism of adipose tissue in obesity and insulin resistance
    Program: VEGA
    Duration: 1. 1. 2017 – 31. 12. 2019
  • New approaches in identification of individual RAS components and function of ACE2/Ang-(1-7)/MasR and (pro)renin receptor pathways in development of adipose tissue hypertrophy
    Program: VEGA
    Duration: 1. 1. 2014 – 31. 12. 2016
  • Centre of excellence for examination of regulatory role of nitric oxide in civilization diseases
    Program:
    Duration: 1. 6. 2011 – 31. 12. 2015
  • The role of 14-3-3 and ASP 160 proteins and adiponectin in adipose tissue compensatory mechanisms during development of obesity and insulin resistance.
    Program: VEGA
    Duration: 1. 1. 2011 – 31. 12. 2013
  • Molecular-genetic alternations in adipose tissue after change in therapy from ACE inhibitors to AT1 receptor blockers in patients with essential hypertension (ADIRAS)
    Program: Other projects
    Duration: 19. 8. 2008 – 31. 12. 2012
  • Neuroendocrine mechanisms participating in induction of insulin resistance in subjects with incipient and non-treated hypertension
    Program: VEGA
    Duration: 1. 1. 2010 – 31. 12. 2012
  • The role of local renin-angiotensin system in the adipose tissue and liver in rat model of obesity and diabetes
    Program: SRDA
    Duration: 1. 1. 2010 – 31. 12. 2011
  • The role of local renin-angiotensin system in hypertrophy of adipose tissue and pathogenesis of insulin resistance
    Program: VEGA
    Duration: 1. 1. 2008 – 31. 12. 2010
  • Study on structure - activity reletionship of insulin analogs modified in the C-terminus of the insulin B-chain
    Program: VEGA
    Duration: 1. 1. 2005 – 1. 12. 2007
Employees